Laigo Bio
Laigo Bio is a SureTACTM precision membrane protein degradation platform founded in 2021 by Neill Moray Mackenzie.
Country
Email Address
Founded Date
2021
Headquarters
Industry
Latest Funding Round Date
December 4, 2025
Latest Funding Round Amount (USD)
13,500,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
13,500,000
Twitter URL
Official Website
Find more companies like Laigo Bio
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.